According to The Times of India newspaper, six countries have already received the Indian Corona vaccine since last Wednesday.
Those six countries are Maldives, Bhutan, Nepal, Seychelles, Myanmar and Bangladesh.
The MOEA (The Indian Ministry of External Affairs) confirmed that the CoVid-19 vaccine which was manufactured in India has now distributed to the above six countries and final clearance is now conducted for three other countries.
Furthermore, The Indian Ministry of External Affairs says that the vaccine will be sent to Sri Lanka within the next couple of weeks.
Due to the heavy demand from Sri Lanka, Afganistan and Mauritius the vaccine will be sent by the beginning of February to those countries.
Currently, India has introduced two vaccines. One is Covshield vaccine and the other is Covaxin.
Covshield was developed by the Serum Institute of India under the licence of the British Oxford-AstraZeneca.
Covaxin was manufactured by Bharath Biotech. Bharath Biotech is an Indian research institute.
Covshield has shown a high rate of success and good performance over the past few months across health workers in India.
The second vaccine Covaxin is still under the observation.
However, due to the situation and high demand, this vaccine was approved by the Government of India for distribution during the first week of January this year.
Therefore, Covaxin will be the second vaccine that India is going to distribute to its neighbouring countries.